Wyndham Hotels & Resorts (WH) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
29 Dec, 2025Executive summary
Achieved record net room growth of 4% in 2024, with 68,700–69,000 rooms opened, the highest annual organic additions in company history, and a global retention rate of 95.7%.
Largest global hotel franchisor with 9,300 hotels, 25 brands, and 903,000 rooms across 95+ countries, with a 70% leisure guest mix and 90% drive-to destinations.
Development pipeline reached a record 252,000 rooms, up 5% year-over-year, with strong expansion in midscale, upscale, and extended-stay segments.
Wyndham Rewards membership reached 114 million, up 8% year-over-year, with increased engagement from younger and higher-income guests.
Strategic focus on high FeePAR development, digital innovation, and capitalizing on U.S. infrastructure spending.
Financial highlights
2024 adjusted EBITDA was $694 million, up 5–7% year-over-year; adjusted free cash flow was $397 million, with a 4.9–5% yield, leading industry peers.
Adjusted diluted EPS for the year was $4.33, up 10% year-over-year; Q4 adjusted diluted EPS up 14% to $1.04.
Returned $430 million to shareholders in 2024 through $308 million in share repurchases and $122 million in dividends.
16–18 consecutive quarters of net room and pipeline growth; global system grew 3.6–4% in 2024.
Q4 net income rose 70% to $85 million; full-year net income was $289 million.
Outlook and guidance
2025 global net room growth expected at 3.6%–4.6%; global RevPAR projected to grow 2%–3% in constant currency.
Fee-related and other revenues expected at $1.49–$1.51 billion; adjusted EBITDA guidance of $745–$755 million, up 7%–9% year-over-year.
Adjusted diluted EPS projected at $4.66–$4.78, up 8%–10%; free cash flow conversion before development advances expected at 57%–60%.
System-wide retention rate expected above 95.7%.
Three-year adjusted EBITDA CAGR of approximately 8.5% targeted through 2026.
Latest events from Wyndham Hotels & Resorts
- Strong 2025 results, robust governance, and ESG focus; board opposes written consent proposal.WH
Proxy filing25 Mar 2026 - Annual meeting to vote on directors, pay, auditor, and written consent proposal.WH
Proxy filing25 Mar 2026 - Record room growth, resilient earnings, and strong capital returns despite RevPAR headwinds.WH
Q4 202519 Feb 2026 - Q2 saw 4% room growth, 22% higher adjusted EPS, and record pipeline expansion.WH
Q2 20242 Feb 2026 - Q3 delivered 4% room growth, $208M EBITDA, record pipeline, and raised 2024 guidance.WH
Q3 202418 Jan 2026 - Record growth, strong financials, and robust governance drive positive outlook for 2025.WH
Proxy Filing1 Dec 2025 - Director elections, executive pay, and auditor ratification headline the annual meeting agenda.WH
Proxy Filing1 Dec 2025 - Record room and pipeline growth, but 2025 guidance lowered on RevPAR softness.WH
Q1 20251 Dec 2025 - System and pipeline growth offset RevPAR declines, driving higher earnings and strong cash returns.WH
Q3 202524 Oct 2025